author-photo

Jan Scicinski

Uniformed Services University of the Health Sciences

86

Papers

1237

Citations

Citation Trend

Filter By

Papers (60) Sort By

Journal Conference Others

Abstract 6381: NBS-1120: An e-NSAID with potent anti-cancer activity targets cell cycle proteins by generating polysulfides

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2186: The novel nitric oxide and hydrogen sulfide releasing anti-cancer agent, NBS-1120, protects the GI tract from the ulcerogenic activity of aspirin and naproxen

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
No patient left behind: The promise of immune priming with epigenetic agents

2017 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (10)
RRx-001 Reset: Chemoresensitization via NO-Mediated M1 Macrophage Repolarization

2017
Show All
- Source
- Cite
- Save
Citations (0)
Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (6)
RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials

2017 Expert Opinion on Investigational Drugs
Show All
- Source
- Cite
- Save
Citations (26)
Abstract 4358: The immunomodulatory anticancer agent RRx-001 induces a vaccine-like interferon response through epigenetic induction of viral mimicry

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Rockets, radiosensitizers, and RRx-001: an origin story part I.

2016 Discovery Medicine
Show All
- Source
- Cite
- Save
Citations (13)
RRx-001, a novel clinical-stage chemosensitizer, radiosensitizer, and immunosensitizer, inhibits glucose 6-phosphate dehydrogenase in human tumor cells.

2016 Discovery Medicine
Show All
- Source
- Cite
- Save
Citations (15)
RRx-001, A novel dinitroazetidine radiosensitizer

2016 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (21)